ARTICLE | Company News
BioSphings AG, Shogoo deal
February 13, 2006 8:00 AM UTC
Shogoo acquired exclusive worldwide rights to develop and commercialize BioSphing's SPK-0601, which is in preclinical development to treat diseases caused by viral infection. Financial terms were not ...